Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
ELVN:NASDAQ
Enliven Therapeutics Inc
41,70 US$
+1,14%
(+0,47) 1D
41,70 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELVN...
Açın
41,26 US$
High
43,57 US$
Low
40,06 US$
Mkt. cap
2,54 mlrd
Avg. vol.
1,55 mln
Volume
542,20K
52-wk high
48,53 US$
52-wk low
14,78 US$
EPS
-1,83 US$
Beta
0,26
Shares outstanding
60,90 mln
No. of employees
60
News stories
From sources across the web
About Enliven Therapeutics Inc
CEO-
Employees60
Founded2016
HeadquartersBoulder, Kolorado, Amerika Birləşmiş Ştatları
SectorPharmaceutical industry
Websiteimaratx.com
Last report
3 mar 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0,48/ (-0,48 est.)USD
-1,05%miss
Revenue / Estimate
-/ (10,00K est.)USD
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
24,90 mln
21,49 mln
18,22 mln
21,24 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,80 mln
7,09 mln
6,87 mln
13,04 mln
Operating expense
31,69 mln
28,58 mln
25,10 mln
34,28 mln
Total operating expenses
31,69 mln
28,58 mln
25,10 mln
34,28 mln
Operating income
-31,69 mln
-28,58 mln
-25,10 mln
-34,28 mln
Other non operating income
-47,00K
-2,00K
-
-
EBT including unusual items
-28,54 mln
-25,34 mln
-20,15 mln
-29,67 mln
EBT excluding unusual items
-28,54 mln
-25,34 mln
-20,15 mln
-29,67 mln
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28,54 mln
-25,34 mln
-20,15 mln
-29,67 mln
Net profit margin
-
-
-
-
Earnings per share
-
-0,49
-0,32
-0,48
Interest and investment income
3,20 mln
3,25 mln
4,95 mln
4,62 mln
Interest expense
-
-
-
-
Net interest expenses
3,20 mln
3,25 mln
4,95 mln
4,62 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,62 mln
-28,50 mln
-25,03 mln
-34,24 mln
Gain or loss from assets sale
-
-
-
106,00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer